Editor-in-Chief: Bijie Hu, MD
Dr. Bijie Hu, is Director of Department of Infectious Diseases, and Director of Department of Hospital Infection Management, at Zhongshan Hospital of Fudan University Shanghai, China.
His professional accomplishments include being Professor and Senior Doctor for the past 15 years at Fudan University, as well as Director of Shanghai Nosocomial Infection Control Center.
He has played an instrumental role in forming and advancing hospital epidemiology, antibiotic stewardship, infection treatment and control. In 2016 he organized the biggest Infectious diseases annual conference in China.
Since 1999, Dr. Hu has published over 150 research articles in peer-reviewed journals and participated in writing 50 book chapters. His research interests range from managing respiratory infections, infectious diseases in ICH and elderly to invasive fungal infections, MDRO infections.
In 2007 and 2014, Dr. Hu was selected as the President of Society of Infection Prevention and Control of China, respectively. He is actively involved in forming and implementing national policies and guidelines for the prevention and control of HAI in healthcare settings. Through Dr. Hu’s dedication and leadership, a group of young and energetic Infection Prevention Professionals is growing rapidly.
Executive Editor-in-Chief: Bing Gu, MD
Dr. Bing Gu, Associate Researcher, Supervisor of Research Master, is a visiting scholar at Purdue University and University of California at Los Angeles (UCLA). He is now Deputy Dean of Medical Technology Institute of Xuzhou Medical University and Vice Director of Department of Laboratory Medicine, the Affiliated Hospital of Xuzhou Medical University.
Dr. Gu is a member of Chinese Committee on Antimicrobial Susceptibility Testing (ChiCAST) of the European Committee for Antimicrobial Susceptibility Testing (EUCAST), World Association of Chinese Clinical Pathologists and Anatomical Pathologists, member of the standing committee of Laboratory Medicine Branch of Chinese Geriatrics Society (CGS), committee member of Clinical Microbiology Branch of Chinese Society of Laboratory Medicine, Infection Control Branch of Chinese Preventive Medicine Association (CPMA), vice chairman of Hospital Infection Control and Medical Research Center of Medical Science and Technology Promotion Committee of China Medicine Education Association (CMEA), Pathogen Detection and Prevention Committee of CGS, chairman of Translational Medicine Committee of Jiangsu Society for Immunology, vice chairman of Youth Committee of Laboratory Medicine Branch of Jiangsu Medical Association, Youth Committee of Jiangsu Society for Immunology. He is also in charge of AME Academic Salon of AME Publishing Company. He is one of the key medical talents of Jiangsu provincial project of “Promoting the Health Service through Science and Education”, an elected member of “333 High-level Talents Training Project”, Provincial High-level Talent Project of “Six Talent Peaks”, and “Advanced Health Talents of ‘Six-one’ Project” of Jiangsu province.
Dr. Gu serves as a reviewer for the National Natural Science Foundation of China (NSFC). He also has taken on the position of Principal Investigator of two projects supported by NSFC, six provincial projects supported by the Natural Science Foundation of Jiangsu Province, one technical innovation group project supported by Xuzhou Medical University. To date, he has published 109 papers as the first author or corresponding author, among which 36 papers have been included in the SCI. Dr. Gu also has authored and published 31 academic monographs and textbooks, eight of which he served as Editor-in-Chief, and he also participated in translation and editing of other eight books as Associate Editor. He won two First Prizes and two Second Prizes of Introduction of Advanced Technology from Jiangsu Provincial Commission of Health and Family Planning, Third Prize of Municipal Award for Science and Technology Progress, Third Prize of Medical Achievement Award from Chinese People's Liberation Army (PLA). Dr. Gu’s research interests include infection prevention and control, mechanism of multidrug resistance bacteria.